These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma midkine level is a prognostic factor for human neuroblastoma. Ikematsu S; Nakagawara A; Nakamura Y; Ohira M; Shinjo M; Kishida S; Kadomatsu K Cancer Sci; 2008 Oct; 99(10):2070-4. PubMed ID: 19016768 [TBL] [Abstract][Full Text] [Related]
5. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873 [TBL] [Abstract][Full Text] [Related]
8. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas. Zhang J; Zheng Y; Wang Y; Tong H J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105 [TBL] [Abstract][Full Text] [Related]
9. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma. Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988 [TBL] [Abstract][Full Text] [Related]
10. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas. Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073 [TBL] [Abstract][Full Text] [Related]
11. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746 [TBL] [Abstract][Full Text] [Related]
12. Midkine as a prognostic biomarker in oral squamous cell carcinoma. Ota K; Fujimori H; Ueda M; Shiniriki S; Kudo M; Jono H; Fukuyoshi Y; Yamamoto Y; Sugiuchi H; Iwase H; Shinohara M; Ando Y Br J Cancer; 2008 Aug; 99(4):655-62. PubMed ID: 18682710 [TBL] [Abstract][Full Text] [Related]
13. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Tsutsui J; Uehara K; Kadomatsu K; Matsubara S; Muramatsu T Biochem Biophys Res Commun; 1991 Apr; 176(2):792-7. PubMed ID: 2025291 [TBL] [Abstract][Full Text] [Related]
14. Expression of TrkA, TrkB and TrkC in human neuroblastomas. Brodeur GM; Nakagawara A; Yamashiro DJ; Ikegaki N; Liu XG; Azar CG; Lee CP; Evans AE J Neurooncol; 1997 Jan; 31(1-2):49-55. PubMed ID: 9049830 [TBL] [Abstract][Full Text] [Related]
15. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581 [TBL] [Abstract][Full Text] [Related]
16. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. Mitsiadis TA; Muramatsu T; Muramatsu H; Thesleff I J Cell Biol; 1995 Apr; 129(1):267-81. PubMed ID: 7698992 [TBL] [Abstract][Full Text] [Related]
17. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Aridome K; Takao S; Kaname T; Kadomatsu K; Natsugoe S; Kijima F; Aikou T; Muramatsu T Br J Cancer; 1998 Aug; 78(4):472-7. PubMed ID: 9716029 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas. Weber A; Huesken C; Bergmann E; Kiess W; Christiansen NM; Christiansen H Clin Cancer Res; 2003 Nov; 9(15):5683-92. PubMed ID: 14654552 [TBL] [Abstract][Full Text] [Related]
19. Serum midkine levels are increased in patients with various types of carcinomas. Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771 [TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. Muramatsu H; Song XJ; Koide N; Hada H; Tsuji T; Kadomatsu K; Inui T; Kimura T; Sakakibara S; Muramatsu T J Biochem; 1996 Jun; 119(6):1171-5. PubMed ID: 8827454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]